Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Fortress Biotech Inc shares valued at $32,724 were purchased by ROSENWALD LINDSAY A MD on Jun 28 ’24. At $1.64 per share, ROSENWALD LINDSAY A MD acquired 20,000 shares. The insider’s holdings grew to 2,893,905 shares worth approximately $5.06 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Klein Dov sold 10,000 shares, netting a total of over 18,900 in proceeds. Following the sale of shares at $1.89 each, the insider now holds 53,400 shares.
Before that, ROSENWALD LINDSAY A MD had added 10,000 shares to its account. In a trade valued at $17,589, the President, CEO & Chairman bought Fortress Biotech Inc shares for $1.76 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $5.03 million.
Analysts at Ladenburg Thalmann started covering the stock with ‘”a Buy”‘ outlook in a report released in early August. As of October 02, 2020, The Benchmark Company has initiated its “Buy” rating for FBIO. Earlier on December 18, 2019, B. Riley FBR initiated its rating. Their recommendation was “a Buy” for FBIO stock.
Analyzing FBIO Stock Performance
During the last five days, there has been a surge of approximately 2.94%. Over the course of the year, Fortress Biotech Inc shares have dropped approximately -41.86%. Shares of the company reached a 52-week high of $3.0700 on 01/02/24 and a 52-week low of $1.6000 on 06/27/24. A 50-day SMA is recorded $1.7952, while a 200-day SMA reached $2.2695. Nevertheless, trading volume fell to 0.19 million shares from 81600.0 shares the previous day.
Support And Resistance Levels for Fortress Biotech Inc (FBIO)
According to the 24-hour chart, there is a support level at 1.6700, which, if violated, would cause prices to drop to 1.5800. In the upper region, resistance lies at 1.8500. The next price resistance is at 1.9400. RSI (Relative Strength Index) is 47.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0512, which suggests the price will decrease in the coming days. Percent R is at 64.44%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
Which companies own the most shares of Fortress Biotech Inc (FBIO)?
On February 28, 2018, B. Riley FBR Inc. assigned a price target of “a Buy” to the stock and initiated coverage with a $10.
